Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2006-04-04 Capital/Financing Update
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG: Ausgabepreis liegt bei 21 Euro
Capital/Financing Update Classification · 98% confidence The document text is a press release from Bio-Gate AG dated April 4, 2006, announcing the final placement price (€21 Euro) for its shares in an Initial Public Offering (IPO) on the Frankfurt Stock Exchange (Entry Standard). It details the subscription volume, the structure of the offering (capital increase and secondary sale), the involvement of investment banks, and the expected first listing date. This content directly relates to fundraising, capital structure changes, and the initial offering of shares to the public, which aligns perfectly with the definition of a Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple dividend notice (DIV).
2006-04-04 German
Bio-Gate AG: Preisspanne liegt zwischen 19 und 21 Euro
Capital/Financing Update Classification · 98% confidence The document text is a press release dated March 24, 2006, detailing the pricing range (€19 to €21), subscription period (March 27 to April 4), and planned listing date (April 5) for the shares of Bio-Gate AG. It explicitly mentions the offering volume, the structure involving a capital increase and secondary sale, and the involvement of investment banks for the IPO process. This content directly relates to the company raising capital through the issuance of new shares and the sale of existing shares, which falls under the 'Capital/Financing Update' category, specifically related to an Initial Public Offering (IPO). The most fitting code is CAP (Capital/Financing Update).
2006-03-24 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.